MATV Stock Analysis: Mativ Holdings | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 668m USD | 12M Return: 15.6% | US8085411069 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.59M
EPS Trend: -37.8%
Qual. Beats: 1
Rev. Trend: -51.5%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Mativ Holdings, Inc. (NYSE: MATV) is a U.S.-based specialty materials manufacturer that operates through two main segments: Filtration & Advanced Materials, and Sustainable & Adhesive Solutions. Its products include engineered polymer and fiber-based substrates, filtration media, tapes, labels, papers, and healthcare materials, serving industries such as transportation, construction, healthcare, packaging, and consumer goods. The company sells its products globally across the Americas, Europe, and the Asia Pacific region, and is headquartered in Alpharetta, Georgia.
The company was originally incorporated in 1995 as Schweitzer-Mauduit International, Inc., a business historically associated with paper manufacturing for the tobacco industry, before rebranding to Mativ Holdings, Inc. in July 2022 following a merger with Neenah, Inc. As a small-cap stock in the Materials sector (GICS Sub Industry: Paper Products), MATV generates revenue by converting specialized paper, film, and fiber inputs into value-added components rather than selling commodity paper grades directly.
- Neenah integration synergies drive margin expansion
- Filtration and Advanced Materials revenue grows on industrial demand
- Resin and polymer cost inflation pressures product margins
| Net Income: 89.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.19 > 1.0 |
| NWC/Revenue: 16.29% < 20% (prev 20.63%; Δ -4.34% < -1%) |
| CFO/TA 0.08 > 3% & CFO 161.0m > Net Income 89.5m |
| Net Debt (1.03b) to EBITDA (123.7m): 8.32 < 3 |
| Current Ratio: 1.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.7m) vs 12m ago 1.93% < -2% |
| Gross Margin: 17.75% > 18% (prev 17.66%; Δ 0.09% > 0.5%) |
| Asset Turnover: 97.76% > 50% (prev 94.73%; Δ 3.03% > 0%) |
| Interest Coverage Ratio: 0.75 > 6 (EBIT TTM 53.8m / Interest Expense TTM 71.5m) |
| A: 0.16 (Total Current Assets 655.2m - Total Current Liabilities 331.3m) / Total Assets 1.99b |
| B: -0.11 (Retained Earnings -215.1m / Total Assets 1.99b) |
| C: 0.03 (EBIT TTM 53.8m / Avg Total Assets 2.03b) |
| D: 0.31 (Book Value of Equity 470.7m / Total Liabilities 1.52b) |
| Altman-Z'' = 1.22 = BB |
| DSRI: 0.97 (Receivables 221.8m/225.5m, Revenue 1.99b/1.97b) |
| GMI: 1.00 (GM 17.66% / 17.75%) |
| AQI: 1.07 (AQ_t 0.35 / AQ_t-1 0.32) |
| SGI: 1.01 (Revenue 1.99b / 1.97b) |
| TATA: -0.04 (NI 89.5m - CFO 161.0m) / TA 1.99b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of October 07, 2026, the stock is trading at USD 12.21 with a total of 387,959 shares traded. Over the past week, the price has changed by +4.09%, over one month by -2.79%, over three months by +65.03% and over the past year by +15.63%.
Current recommended Stop Loss: 11.30 (which is 7.5% or 2 ATR below the current price).
Mativ Holdings has no consensus analysts rating.
| Analysts Target Price | 21 | 72% |
P/E Trailing = 7.3841
P/E Forward = 10.0503
P/S = 0.3362
P/B = 1.4727
P/EG = 1.8363
Revenue TTM = 1.99b USD
EBIT TTM = 53.8m USD
EBITDA TTM = 123.7m USD
Long Term Debt = 970.1m USD (from longTermDebt, last quarter)
Short Term Debt = 13.4m USD (from shortTermDebt, last quarter)
Debt = 1.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 60.4m
Net Debt = 1.03b USD (calculated: Debt 1.10b - CCE 66.3m)
Enterprise Value = 1.70b USD (668.4m + Debt 1.10b - CCE 66.3m)
Interest Coverage Ratio = 0.75 (Ebit TTM 53.8m / Interest Expense TTM 71.5m)
EV/FCF = 13.29x (Enterprise Value 1.70b / FCF TTM 127.7m)
FCF Yield = 7.52% (FCF TTM 127.7m / Enterprise Value 1.70b)
FCF Margin = 6.42% (FCF TTM 127.7m / Revenue TTM 1.99b)
Net Margin = 4.50% (Net Income TTM 89.5m / Revenue TTM 1.99b)
Gross Margin = 17.75% ((Revenue TTM 1.99b - Cost of Revenue TTM 1.64b) / Revenue TTM)
Gross Margin QoQ = 21.31% (prev 14.37%)
Tobins Q-Ratio = 0.85 (Enterprise Value 1.70b / Total Assets 1.99b)
Interest Expense / Debt = 6.53% (Interest Expense 71.5m / Debt 1.10b)
Taxrate = 47.06% (3.20m / 6.80m)
NOPAT = 28.5m (EBIT 53.8m * (1 - 47.06%))
Current Ratio = 1.98 (Total Current Assets 655.2m / Total Current Liabilities 331.3m)
Debt / Equity = 2.33 (Debt 1.10b / totalStockholderEquity, last quarter 470.7m)
Debt / EBITDA = 8.32 (Net Debt 1.03b / EBITDA 123.7m)
Debt / FCF = 8.06 (Net Debt 1.03b / FCF TTM 127.7m)
Total Stockholder Equity = 459.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.40% (Net Income 89.5m / Total Assets 1.99b)
RoE = 19.47% (Net Income TTM 89.5m / Total Stockholder Equity 459.8m)
RoCE = 3.76% (EBIT 53.8m / Capital Employed (Equity 459.8m + L.T.Debt 970.1m))
RoIC = 1.77% (NOPAT 28.5m / Invested Capital 1.61b)
WACC = 7.19% (E(668.4m)/V(1.76b) * Re(13.31%) + D(1.10b)/V(1.76b) * Rd(6.53%) * (1-Tc(0.47)))
Discount Rate = 13.31% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 81.21 | Cagr: 1.15%
[DCF] Terminal Value 77.97% ; FCFF base≈95.1m ; Y1≈109.0m ; Y5≈160.4m
[DCF] Fair Price = 25.08 (EV 2.41b - Net Debt 1.03b = Equity 1.38b / Shares 55.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -37.83 | EPS CAGR: -14.42% | SUE: 3.16 | # QB: 1
Revenue Correlation: -51.53 | Revenue CAGR: -2.00% | SUE: 1.53 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.25 | Chg30d=-26.47% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=0.97 | Chg30d=+14.12% | Revisions=-40% | GrowthEPS=+38.6% | GrowthRev=+1.8%
EPS next Year (2027-12-31): EPS=1.25 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+28.9% | GrowthRev=+3.3%